Inclusion Criteria:  Women aged > or = 18 years. Ability to read and understand English. Access to internet.  Early-stage breast/gynaecologic cancer within 12 months of completion of primary curative therapy:  Breast cancer: Stage I-III hormone receptor-positive (defined as estrogen receptor and/or progesterone receptor ≥ 1%) and HER2-negative per ASCO-CAP guidelines on or recommended to commence adjuvant endocrine therapy during the study period. Cervical cancer: Stage I to III treated with curative intent. Endometrial cancer: treated with curative intent adjuvant radiotherapy +/- chemotherapy  Exclusion Criteria:  Patients who are not treated with curative intent as above. Patients with premalignant disease. Persons who, in the opinion of the researcher or supervising clinician, are unable to cooperate adequately with the study protocol. Recent (within 12 months) participation in a study/programme involving a lifestyle intervention (e.g diet, exercise, survivorship). Note: Per discretion of PI as to whether may impact the outcome of this study intervention.